Publications by authors named "Shanti Pather"

Claim this Profile
S
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.
Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, Ruben Rizzi, Federico J Mensa, Shanti Pather

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary.
Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa

Expert Rev Vaccines· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine.
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, Ruben Rizzi, Andrew Finlayson

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review.
David J Weber, Kanecia O Zimmerman, Sara Y Tartof, John M McLaughlin, Shanti Pather

Vaccines (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19-Related Work Absenteeism and Associated Lost Productivity Cost in Germany: A Population-Based Study.
Jingyan Yang, Kiran K Rai, Monica Seif, Hannah R Volkman, Jinma Ren, Shanti Pather

J Occup Environ Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines.
George Kassianos, Pauline MacDonald, Ivan Aloysius, Shanti Pather

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era.
Shanti Pather, Alexander Muik, Ruben Rizzi, Federico Mensa

Expert Rev Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.
Shanti Pather, Shabir A Madhi, Benjamin J Cowling, Paul Moss, Jeremy P Kamil

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.
Shanti Pather, Shabir A Madhi, Benjamin J Cowling, Paul Moss, Jeremy P Kamil

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review.
Jaime Fergie, Mary M Moran, Alejandro Cane, Shanti Pather, Ӧzlem Türeci

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, Shanti Pather

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing COVID-19 vaccine hesitancy.
George Kassianos, Joan Puig-Barberà, Hannah Dinse, Martin Teufel, Özlem Türeci, Shanti Pather

Drugs Context· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development and approval of COVID-19 vaccines.
Ulrich Kalinke, Dan H Barouch, Ruben Rizzi, Eleni Lagkadinou, Özlem Türeci, Shanti Pather

Expert Rev Vaccines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.
Gary McLean, Jeremy Kamil, Benhur Lee, Penny Moore, Thomas F Schulz, Shanti Pather

mBio· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis